A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DNase I / deoxyribonuclease I

[Related PubMed/MEDLINE]
Total Number of Papers: 269
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DNase I  (>> Co-occurring Abbreviation)
Long Form:   deoxyribonuclease I
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Anti-DNase I Antibody: A New Serological Reactivity in Primary Sjogren Syndrome. pSS, RA
2020 Deoxyribonuclease Reduces Tissue Injury and Improves Survival After Hemorrhagic Shock. DAMPs, HS
2020 Enhanced eradication of bacterial biofilms with DNase I-loaded silver-doped mesoporous silica nanoparticles. ---
2019 A practical guide for DNase-seq data analysis: from data management to common applications. ---
2019 Circulating cell-free DNA fragment analysis by microchip electrophoresis and its relationship with DNase I in cardiac diseases. cfDNA, MI
2019 DNase-seq to Study Chromatin Accessibility in Early Xenopus tropicalis Embryos. DHSs, qPCR
2019 Evaluation of the functional effects of genetic variants‒missense and nonsense SNPs, indels and copy number variations‒in the gene encoding human deoxyribonuclease I potentially implicated in autoimmunity. DNASE1, SNPs
2019 Facile core-shell nanoparticles with controllable antibacterial activity assembled by chemical and biological molecules. CPNs, dsDNA
2019 Immobilization-free photoelectrochemical aptasensor for environmental pollutants: Design, fabrication and mechanism. ATZ, MCT, NPs, NTs, PEC
10  2019 Mining Clinical Case Reports to Identify New Lines of Investigation in Alzheimer's Disease: The Curious Case of DNase I. ---
11  2019 Organochlorinated pesticides expedite the enzymatic degradation of DNA. HCHs
12  2019 Purification of silica-free DNA and characterization of its role in coagulation. DBL-DNA, PAX-DNA, polyP, silica-DNA
13  2019 Synthesis and DNase I inhibitory properties of some 4-thiazolidinone derivatives. ---
14  2019 [Significance of neutrophil extracellular trap and its markers in the early diagnosis of community-acquired pneumonia in children]. AUC, CAP, cfDNA, CRP, NET, ROC, WBC
15  2018 A signal-on, colorimetric determination of deoxyribonuclease I activity utilizing the photoinduced synthesis of gold nanoparticles. PS, Thr
16  2018 Benzimidazoles as novel deoxyribonuclease I inhibitors. RQSAR
17  2018 Graphene oxide-based fluorometric determination of methicillin-resistant Staphylococcus aureus by using target-triggered chain reaction and deoxyribonuclease-assisted recycling. GO, MRSA
18  2018 STING Signaling Promotes Inflammation in Experimental AcutePancreatitis. AP, cGAS
19  2017 A label-free fluorescent assay for deoxyribonuclease I activity based on DNA-templated silver nanocluster/graphene oxide nanocomposite. ---
20  2017 A label-free fluorometric assay for actin detection based on enzyme-responsive DNA-templated copper nanoparticles. dsDNA
21  2017 Apoptosis of keratinocytes and serum DNase I activity in patients with cutaneous lupus erythematosus: relationship with clinical and immunoserological parameters. AI, CLE, DLE, SCLE, SLE
22  2017 Different effects of matrix degrading enzymes towards biofilms formed by E. faecalis and E. faecium clinical isolates. AlgL
23  2017 Effects of DNase I coating of titanium on bacteria adhesion and biofilm formation. eDNA, S. aureus, S. mutans, Ti
24  2017 Label-free and sensitive assay for deoxyribonuclease I activity based on enzymatically-polymerized superlong poly(thymine)-hosted fluorescent copper nanoparticles. TdT
25  2017 Mechanism of graphene-induced cytotoxicity: Role of endonucleases. EndoG, HO-1, Hsp90, TUNEL
26  2016 Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. ANCA, BVAS, cit-H3-DNA, CRP, eGFR, NETs
27  2016 DNaseI aggravates islet beta-cell apoptosis in type2 diabetes. siRNA
28  2016 Mapping nucleosome positions using DNase-seq. MNase, TF
29  2016 Three-Enzyme Cascade Bioreactor for Rapid Digestion of Genomic DNA into Single Nucleosides. 8-oxodG, ALPase, SVP
30  2016 [Correlation of DNase I in serum and synovial fluid with inflammatory activity in patients with rheumatoid arthritis]. AS, GA, RA, SF
31  2015 Effect of DNase treatment on RNA extraction from preimplantation murine embryos. RT-qPCR
32  2015 gamma-H2AX induced by linear alkylbenzene sulfonates is due to deoxyribonuclease-1 translocation to the nucleus via actin disruption. DSBs, LAS
33  2015 Global analysis of genetic variations in a 56-bp variable number of tandem repeat polymorphisms within the human deoxyribonuclease I gene. ---
34  2015 Homogeneous Immunochemical Assay on the Lateral Flow Strip for Measurement of DNase I Activity. ---
35  2015 Hyphenation of a Deoxyribonuclease I immobilized enzyme reactor with liquid chromatography for the online stability evaluation of oligonucleotides. IEC, IMER, IPC, LC, ONs
36  2015 Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion. mtDNA
37  2015 New mechanism of gamma-H2AX generation: Surfactant-induced actin disruption causes deoxyribonuclease I translocation to the nucleus and forms DNA double-strand breaks. NPEOs
38  2015 Novel high-throughput deoxyribonuclease 1 assay. ---
39  2014 Multi-responsive and logic controlled release of DNA-gated mesoporous silica vehicles functionalized with intercalators for multiple delivery. MSN
40  2013 A label-free near-infrared fluorescent assay for the determination of deoxyribonuclease I activity based on malachite green/G-quadruplexes. MG, NIR, ssDNA
41  2013 Characterization of extracellular polymeric matrix, and treatment of Fusobacterium nucleatum and Porphyromonas gingivalis biofilms with DNase I and proteinase K. eDNA, EPM
42  2013 Cyclically amplified fluorescent detection of theophylline and thiamine pyrophosphate by coupling self-cleaving RNA ribozyme with endonuclease. GO, SD, TPP
43  2013 Enhancing the selectivity of enzyme detection by using tailor-made nanoparticles. ---
44  2013 Novel high-sensitive fluorescent detection of deoxyribonuclease I based on DNA-templated gold/silver nanoclusters. HPLC
45  2013 Plasmonic Core-Satellites Nanostructures with High Chirality and Bioproperty. CD, PCD, SPR
46  2013 Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement. ANA, IIF, SLE
47  2012 A graphene-based real-time fluorescent assay of deoxyribonuclease I activity and inhibition. dsDNA, FAM, GO, ssDNA
48  2012 Serum deoxyribonuclease I activity can be a useful diagnostic marker for the early diagnosis of unstable angina pectoris or non-ST-segment elevation myocardial infarction. CPS, NSTEMI, UAP, UAP/NSTEMI
49  2011 Cytosine-phosphodiester-guanine oligodeoxynucleotide (CpG ODN)-capped hollow mesoporous silica particles for enzyme-triggered drug delivery. CpG ODN, HMS
50  2011 Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination. DPPC, NPs, PLGA
51  2011 Impaired deoxyribonuclease I activity in patients with inflammatory bowel diseases. CD, IBD, UC
52  2011 Rapid measurement of deoxyribonuclease I activity with the use of microchip electrophoresis based on DNA degradation. AMI
53  2010 A biochemical and genetic study on all non-synonymous single nucleotide polymorphisms of the gene encoding human deoxyribonuclease I potentially relevant to autoimmunity. ---
54  2009 Determination of a transcription factor-binding site by nuclease protection footprinting onto southwestern blots. SW
55  2009 Development of a sensitive enzyme-linked immunosorbent assay for measurement of DNase I in human serum. AMI, SRED
56  2009 DNase I inhibits a late phase of reactive oxygen species production in neutrophils. NETs, ROS
57  2009 Enzymatic conversion of long DNA to small DNA fragments for the construction of short hairpin RNA expression libraries. dsDNA, shRNA
58  2009 Footprinting DNA-protein interactions in native polyacrylamide gels by chemical nucleolytic activity of 1,10-phenanthroline-copper. DMS, EMSA, OP-Cu
59  2009 Gln222Arg (A2317G) polymorphism in the deoxyribonuclease I gene exhibits ethnic and functional differences. SNP
60  2009 Impact of incomplete DNase I treatment on human macrophage proteome analysis. ---
61  2009 Interaction of diphtheria toxin (fragment A) with actin. DT, FA, G-actin, HUVEC
62  2009 Levels of serum deoxyribonuclease I activity on admission in patients with acute myocardial infarction can be useful in predicting left ventricular enlargement due to remodeling. AMI, LV, LVEDV, LVEF, LVESV
63  2009 Optimized sample preparation for two-dimensional gel electrophoresis of soluble proteins from chicken bursa of Fabricius. BF, CHAPS, DTT, IEF, IPG, MALDI-TOF MS, PMSF, RNase A
64  2009 Serum deoxyribonuclease I can be used as a useful marker for diagnosis of death due to ischemic heart disease. AMI, CAG, PCI, VSAP
65  2009 Uptake of foreign nucleic acids in kidney tubular epithelial cells deficient in proapoptotic endonucleases. EndoG, KO
66  2008 Cross-linked long-pitch actin dimer forms stoichiometric complexes with gelsolin segment 1 and/or deoxyribonuclease I that nonproductively interact with myosin subfragment 1. ABPs, ANP
67  2008 Deoxyribonuclease I gene polymorphism in Han Chinese population: frequency and effect on glucose and lipid parameters. ---
68  2008 DNase I-tRNA interaction. ---
69  2008 Electrochemical assay for deoxyribonuclease I activity. ---
70  2008 Extremely high prevalence of DNASE1*1 allele in African populations. PCR-RFLP, SNP
71  2008 Study of protein conformational stability and integrity using calorimetry and FT-Raman spectroscopy correlated with enzymatic activity. FT, HSDSC, LDH, Tm
72  2008 The functions of Deoxyribonuclease II in immunity and development. DNase II
73  2008 Two N-linked glycosylation sites (Asn18 and Asn106) are both required for full enzymatic activity, thermal stability, and resistance to proteolysis in mammalian deoxyribonuclease I. ---
74  2007 DNAse I pre-treatment markedly enhances detection of nuclear cyclin-dependent kinase inhibitor p57Kip2 and BrdU double immunostaining in embryonic rat brain. BrdU, CKIs
75  2007 Hypoxia induces upregulation of the deoxyribonuclease I gene in the human pancreatic cancer cell line QGP-1. ---
76  2007 Inhibitiory effects of gold(III) ions on ribonuclease and deoxyribonuclease. RNase A
77  2007 Mapping the ADF/cofilin binding site on monomeric actin by competitive cross-linking and peptide array: evidence for a second binding site on monomeric actin. ADF, DbP, Tbeta4
78  2007 Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test. VSAP
79  2007 Susceptibility of mammalian deoxyribonucleases I (DNases I) to proteolysis by proteases and its relationships to tissue distribution: biochemical and molecular analysis of equine DNase I. DNases I
80  2007 Two deoxyribonuclease I gene polymorphisms and correlation between genotype and its activity in Japanese population. SNP, VNTR
81  2006 Actin-inhibition and folding of vertebrate deoxyribonuclease I are affected by mutations at residues 67 and 114. aa
82  2006 Association of Gln222Arg polymorphism in the deoxyribonuclease I (DNase I) gene with myocardial infarction in Japanese patients. AP, CI, MI
83  2006 Characterization of human deoxyribonuclease I gene (DNASE1) promoters reveals the utilization of two transcription-starting exons and the involvement of Sp1 in its transcriptional regulation. ---
84  2006 Deoxyribonuclease I footprinting reveals different DNA binding modes of bifunctional platinum complexes. ---
85  2006 Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations. SNP, VNTR
86  2006 One-step purification of mammalian deoxyribonucleases I and differences among pancreas, parotid, and pancreas-parotid (mixed) types based on species- and organ-specific N-linked glycosylation. endo H, PNGase F
87  2006 Stabilisation of deoxyribonuclease in hydrofluoroalkanes using miscible vinyl polymers. DTPVA, HFA, MDI, PVA, PVP
88  2005 Analysis of genetic polymorphism of deoxyribonuclease I in Ovambo and Turk populations using a genotyping method. PCR
89  2005 Carp liver DNase--isolation, further characterization and interaction with endogenous actin. ---
90  2005 Cisplatin nephrotoxicity is mediated by deoxyribonuclease I. KO
91  2005 Clinical applications of DNase I, a genetic marker already used for forensic identification. ---
92  2005 Identification of a deoxyribonuclease I inhibitor from a phage-peptide library. ---
93  2005 Preparation of poly(ethylene glycol)-introduced cationized gelatin as a non-viral gene carrier. PEG
94  2005 Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischaemia induced by percutaneous coronary intervention. c-TnT, CAG, CK-MB, PCI
95  2005 The cytolethal distending toxin B sub-unit of Helicobacter hepaticus is a Ca2+- and Mg2+-dependent neutral nuclease. CdtB
96  2004 A novel 56-bp variable tandem repeat polymorphism in the human deoxyribonuclease I gene and its population data. ---
97  2004 Cytolethal distending toxins. CDTs, DSBs
98  2004 Diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction. AMI
99  2004 Effects of lipopolysaccharide on actin reorganization and actin pools in endothelial cells. FITC, LPS
100  2004 Localization of selenium-binding protein at the tips of rapidly extending protrusions. SBP